Cite
APA Citation
Tourneau, C. L., Cassier, P., Rolland, F., Salas, S., Limacher, J. M., Capitain, O., Lantz, O., Lalanne, A., Ekwegbara, C., Tavernaro, A., Makhloufi, H., Bendjama, K., & Delord, J. (n.d.). 793 TG4001 (Tipapkinogene sovacivec) and avelumab for recurrent/metastatic (R/M) human papilloma virus (HPV)-16+ cancers: clinical efficacy and immunogenicity. Journal for immunotherapy of cancer, 8, A474. http://access.bl.uk/ark:/81055/vdc_100144715758.0x000005